"UM Upper Chesapeake Medical Center offers the residents of northeastern Maryland an unparalleled combination of clinical expertise, leading-edge technology, and an exceptional patient experience. We are dedicated to maintaining and improving the health of community by providing high quality care for all."

During the past decade, UM Upper Chesapeake Medical Center conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 20 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 16 clinical trials were completed. i.e. 64% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UM Upper Chesapeake Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "NRG Oncology" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored and "University of Maryland, Baltimore" with 10 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UM Upper Chesapeake Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "UM Upper Chesapeake Medical Center" are "Invasive Breast Carcinoma" (5 trials), "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Metastatic Malignant Neoplasm in the Brain" (4 trials), "Recurrent Breast Carcinoma" (4 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials). Many other conditions were trialed in "UM Upper Chesapeake Medical Center" in a lesser frequency.

Most popular intervention types in "UM Upper Chesapeake Medical Center" are "Drug" (48 trials), "Other" (46 trials), "Radiation" (35 trials), "Biological" (23 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (23 trials), "Laboratory Biomarker Analysis" (18 trials), "Questionnaire Administration" (18 trials), "Paclitaxel" (12 trials) and "Cisplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "UM Upper Chesapeake Medical Center" are 60 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "UM Upper Chesapeake Medical Center". undefined are not yet recruiting, 28 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in UM Upper Chesapeake Medical Center, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in UM Upper Chesapeake Medical Center, 2 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

UM Upper Chesapeake Medical Center has several departments that took part in Clinical trials: "UCH Kaufman Cancer Center" - 2 trials